Hangyu Zhang Selected Research

Amyloidogenic Proteins

6/2013

In vitro study of α-synuclein protofibrils by cryo-EM suggests a Cu(2+)-dependent aggregation pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hangyu Zhang Research Topics

Disease

14	Neoplasms (Cancer) 03/2024 - 11/2016
6	Hepatocellular Carcinoma (Hepatoma) 03/2024 - 01/2019
6	Colorectal Neoplasms (Colorectal Cancer) 12/2023 - 02/2017
5	Neoplasm Metastasis (Metastasis) 02/2024 - 02/2017
3	Disease Progression 01/2023 - 03/2019
3	Microsatellite Instability 01/2023 - 10/2020
2	Colonic Neoplasms (Colon Cancer) 02/2024 - 10/2020
2	Pancreatic Neoplasms (Pancreatic Cancer) 09/2023 - 01/2023
2	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2023 - 10/2022
2	Urinary Bladder Neoplasms (Bladder Cancer) 01/2020 - 01/2020
1	Cytokine Release Syndrome 09/2023
1	Alzheimer Disease (Alzheimer's Disease) 08/2023
1	Fibrosis (Cirrhosis) 08/2023
1	Inflammation (Inflammations) 08/2023
1	Hematologic Neoplasms (Hematological Malignancy) 03/2022
1	Breast Neoplasms (Breast Cancer) 01/2022
1	Hepatitis B 01/2020
1	Infections 01/2020
1	HIV Infections (HIV Infection) 10/2018
1	Biliary Tract Neoplasms (Biliary Tract Cancer) 01/2018
1	Stomach Neoplasms (Stomach Cancer) 11/2016
1	Glioblastoma (Glioblastoma Multiforme) 11/2016
1	Parkinson Disease (Parkinson's Disease) 08/2015
1	Nervous System Diseases (Neurological Disorders) 06/2013

Drug/Important Bio-Agent (IBA)

5	Immune Checkpoint InhibitorsIBA 02/2023 - 01/2020
4	Proteins (Proteins, Gene)FDA Link 11/2022 - 11/2016
3	Irinotecan (Camptosar)FDA LinkGeneric 02/2023 - 01/2018
2	Biomarkers (Surrogate Marker)IBA 03/2024 - 01/2022
2	Monoclonal AntibodiesIBA 02/2024 - 10/2018
2	AntigensIBA 09/2023 - 01/2020
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2023 - 02/2017
2	Cetuximab (Erbitux)FDA Link 05/2020 - 03/2019
2	Gemcitabine FDA Link 01/2020 - 01/2018
2	Cisplatin (Platino)FDA LinkGeneric 01/2020 - 01/2018
2	Programmed Cell Death 1 ReceptorIBA 01/2020 - 01/2019
2	Circulating Tumor DNAIBA 03/2019 - 01/2019
1	Eosine Yellowish-(YS) (Eosin)IBA 12/2023
1	Hematoxylin (Haematoxylon)IBA 12/2023
1	EmulsionsIBA 09/2023
1	Lipase (Acid Lipase)FDA Link 09/2023
1	GlypicansIBA 09/2023
1	Amyloid (Amyloid Fibrils)IBA 08/2023
1	Peptides (Polypeptides)IBA 08/2023
1	Fluorouracil (Carac)FDA LinkGeneric 02/2023
1	Cadherins (E-Cadherin)IBA 01/2022
1	VimentinIBA 01/2022
1	Apolipoprotein C-I (Apolipoprotein C1)IBA 01/2022
1	Scavenger Receptors (Scavenger Receptor)IBA 01/2021
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2020
1	B7-H1 AntigenIBA 01/2020
1	Antiviral Agents (Antivirals)IBA 01/2020
1	Tyrosine Kinase InhibitorsIBA 01/2020
1	pazopanib FDA Link 01/2020
1	nuclear matrix protein 22IBA 01/2020
1	CateninsIBA 10/2019
1	ErbB Receptors (EGF Receptor)IBA 03/2019
1	brigatinibIBA 01/2019
1	CrizotinibIBA 01/2019
1	Adenosine Triphosphatases (ATPase)IBA 12/2018
1	indoleIBA 12/2018
1	Messenger RNA (mRNA)IBA 12/2018
1	Protease Inhibitors (Protease Inhibitor)IBA 10/2018
1	IntegrinsIBA 10/2018
1	LigandsIBA 10/2018
1	Liposomes (Liposome)IBA 11/2016
1	Recombinant ProteinsIBA 11/2016
1	SynucleinsIBA 08/2015
1	Amyloidogenic ProteinsIBA 06/2013

Therapy/Procedure

9	Therapeutics 08/2023 - 01/2018
8	Immunotherapy 03/2024 - 01/2019
5	Drug Therapy (Chemotherapy) 02/2024 - 02/2017
2	Adjuvant Chemotherapy 02/2024 - 11/2020
2	Aftercare (After-Treatment) 09/2023 - 05/2020
1	Injections 09/2023
1	Blood Transfusion (Blood Transfusions) 11/2020
1	Length of Stay 11/2020
1	Precision Medicine 01/2019
1	Intramuscular Injections 11/2016